Chris Alderson

Chris specialises in healthcare law.  He undertakes defendant clinical negligence litigation, including claims of utmost severity on behalf of NHS clients and represents such clients at inquests, including Article 2 and jury inquests. 

Chris is also an expert in the field of information governance, and regularly advises NHS and other healthcare providers, third sector entities and tech start ups in the field. He also provides advice on transactional work involving a change in usage of personal data. Recent work in this area has included advising an NHS body in relation to the IG issues in a major NHS Test Bed project, and preparing clients for GDPR implementation.

Chris’s advice has covered matters relating to patient information and confidentiality, including data security breaches and the associated monetary penalties, and commercially sensitive information, in particular in relation to contentious procurement issues.

Chris also advises on public interest disclosures of information and has advised recently on disclosures of information with a national high profile, including those concerning safeguarding children. Chris also lectures and publishes articles on wider issues of information governance with a particular emphasis on the health sector.

Main areas of expertise

  • Information governance
  • Clinical negligence litigation
  • Inquests

The clients he works with

  • NHS foundation trusts
  • NHS trusts
  • Primary Care Trusts
  • Healthcare practitioners
  • Medical Defence Organisations
  • Charities
  • Third sector organisations

Professional memberships

The Law Society

EventsView all

Things you need to know about information governance to sell healthtech products into the NHS

The NHS encourages innovation in using technology in developing new and better ways of delivering care, managing health conditions and reducing hospital conditions. It is also a key marketplace for such products. NHS organisations also have large databases of patient related health data, which have the potential to be vital source of information for analysis and development of healthtech products. However, the NHS internal information governance rules place strict controls on the use of patient identifiable data including for cutting edge artificial intelligence products. Any healthtech product must be capable of operating within this framework in order to be a viable product to offer to NHS customers. This session will provide an introduction to the relevant rules and principles and sources of guidance and advice to technology companies seeking to develop products for this sector, including an overview of the role of anonymisation and psuedonymisation (including the use of controlled environments) and section 251 authorisations.

View Event

NewsView all